Brand:
BBCA PHARMAGoods Stock:
50000000Payment:
L/C, T/T, MoneyGramProduct Origin:
ChinaColor:
colorless or nearly colorless transparent liquid
2. Component: Ofloxacin and glucose.Main ingredients: ofloxacin.
3. Appearance: Colorless or colorless clear liquid
4. Indications:
Suitable for sensitive bacteria caused by:
(1)Urinary reproductive system infection, including simple and complicated urinary tract infection, bacterial prostatitis, bacteria neisseria gonorrhea urethritis and cervicitis (including enzyme production strains caused by).
(2)Respiratory tract infections, including sensitive acute bronchial infection caused by gram-negative bacilli and lung infection.
(3)Gastrointestinal tract infection, by shigella, salmonella and e. coli to produce enterotoxin, moisture, deputy hemolytic bacterium vibrio, etc.
(4)Typhoid.
(5)Bone and joint infections.
(6)Skin soft tissue infection.
(7)Sepsis and systemic infection.
5. Drug interactions:
(1)Urine, agents can reduce the product solubility in the urine, cause crystallization urine and kidney toxicity.
(2)Quinolone antibacterial and theophylline class share may be due to combined with the cytochrome P450 when parts of a competitive inhibition, seriously reduce the liver to eliminate theophylline class, blood elimination half-life (t1/2 beta), blood drug concentration increases, theophylline poisoning symptoms, such as nausea, vomiting, tremor, anxiety, excitement, convulsions, heart palpitations and so on.Metabolic effects of theophylline, although small, but share when should still determination of theophylline blood drug concentration and dose adjustment.
(3)This product with ring spore share, can make the ring spore elevated blood drug concentration, must monitor ring spore blood concentration, and adjust the dosage.
(4)This product and share the anti-clotting drug warfarin is smaller in the latter the anticoagulant effect of enhanced, but also should closely monitor patients when sharing the prothrombin time.
(5)Probenecid can reduce the product since the renal tubular secretion by about 50%, when share can produce because of the product increased blood levels of toxicity.
(6)The product can interfere with the metabolism of caffeine, which can lead to eliminate caffeine reduce, eliminate blood half-life (t1/2 beta) extended, and the central nervous system toxicity may be produced.
6. Storage: Protect from light, airtight preservation.
Pls contact:latikajiang@bbcapharma.com